ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)

ClinicalTrials.gov ID: NCT06962800

Public ClinicalTrials.gov record NCT06962800. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 2:40 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Multicenter, Randomized Phase 3 Study Evaluating the Efficacy and Safety of Felzartamab in Participants With Primary Membranous Nephropathy (PMN) [PROMINENT]

Study identification

NCT ID
NCT06962800
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Biogen
Industry
Enrollment
180 participants

Conditions and interventions

Conditions

Not listed

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 21, 2025
Primary completion
Dec 28, 2028
Completion
Mar 28, 2029
Last update posted
May 4, 2026

2025 – 2029

United States locations

U.S. sites
12
U.S. states
8
U.S. cities
12
Facility City State ZIP Site status
Apogee Clinical Research, LLC Huntsville Alabama 35805-4104 Recruiting
The Nephrology Group, Inc. - Fresno Fresno California 93720-2989 Recruiting
Academic Medical Research Institute Los Angeles California 90022 Recruiting
UCSF Medical Center San Francisco California 94143-2205 Recruiting
Henry Ford Hospital- A-Basement Research Pharmacy Detroit Michigan 48202-2608 Recruiting
Elixia Health - Michigan Kidney Consultants, LLC - Elixia - PPDS Pontiac Michigan 48341 Completed
James J Peters Veterans Administration Medical Center - NAVREF - PPDS The Bronx New York 10468 Recruiting
ECU Physicians Nephrology and Hypertension Greenville North Carolina 27834 Recruiting
Knoxville Kidney Center, PLLC Knoxville Tennessee 37923-3624 Recruiting
Nephrotex Research Group Dallas Texas 75231-0929 Recruiting
University of Texas Medical Branch League City Texas 77573 Recruiting
University of Wisconsin School of Medicine and Public Health Madison Wisconsin 53792-0001 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06962800, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 4, 2026 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06962800 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →